Lombard Medical Technologies PLC Share Option Grant (0356H)
June 14 2013 - 2:00AM
UK Regulatory
TIDMLMT
RNS Number : 0356H
Lombard Medical Technologies PLC
14 June 2013
Lombard Medical Technologies PLC
("Lombard Medical" or the "Company")
Share Option Grant
London, UK, 14 June 2013 - Lombard Medical Technologies PLC
(AIM:LMT), the specialist medical technology company focussed on
innovative vascular products, announces that it has yesterday,
under the Company's Share Option Plan (2005), granted 3,209,394 new
share options over ordinary shares of 20p each in the Company, at
an exercise price of 177.5 pence per share, to its Directors and
employees. Following this grant, there will be 5,342,607 share
options in issue, representing 11.9% of the Company's issued
shares, calculated including the shares to be issued following the
Placing, Subscription and Offer and conversion of Convertible Loan
Notes announced on 24 May 2013; the share options in issue to the
Directors will represent 7.4% of this issued shares figure.
The vesting of the share options will be subject to certain
performance criteria that have been determined by the Company's
Remuneration Committee to reflect the Company's current and future
business plans and are based on the achievement by the Company of a
majority of budgeted revenue.
In order to achieve the most tax efficient status, the share
options have been granted ahead of the Company's General Meeting
which will be held later today and at which shareholders will vote
on resolutions supporting the fundraising announced on 24 May 2013.
Given the timing of this grant, the share options will have an
additional performance condition, being the passing by shareholders
of resolutions 1 and 2 at the General Meeting.
The number of share options granted to each of the Directors is
as shown in the table below:
Director Share options Total share options Total share
the subject held following options held
of this grant this grant following this
grant as a percentage
of the Company's
issued shares
John Rush 120,902 338,371 0.76%
--------------- -------------------- -----------------------
Simon Hubbert 787,847 1,342,295 3.00%
--------------- -------------------- -----------------------
Ian Ardill 245,813 447,431 1.00%
--------------- -------------------- -----------------------
Peter Phillips 469,531 671,147 1.50%
--------------- -------------------- -----------------------
Simon Neathercoat 90,708 199,442 0.45%
--------------- -------------------- -----------------------
Craig Rennie 76,513 157,160 0.35%
--------------- -------------------- -----------------------
Martin Rothman 76,513 157,160 0.35%
--------------- -------------------- -----------------------
-Ends-
Enquiries:
Lombard Medical Technologies PLC Tel: 01235 750 800
Simon Hubbert, Chief Executive Officer
Ian Ardill, Chief Financial Officer
Canaccord Genuity Limited Tel: 020 7523 8000
Lucy Tilley / Henry Fitzgerald O'Connor
/ Dr. Julian Feneley
FTI Consulting
Simon Conway / Susan Stuart / Victoria Tel: 020 7831 3113
Foster Mitchell
About Lombard Medical
Lombard Medical Technologies PLC (AIM: LMT), is a medical device
company focused on device solutions for the $1.2 billion dollar per
annum abdominal aortic aneurysm (AAA) repair market. AAAs are a
balloon-like enlargement of the aorta which, if left untreated, may
rupture and cause death. Approximately 4.5 million people are
living with AAAs in the developed world and each year 600,000 new
cases are diagnosed. The market for endovascular stent grafts for
this application is expected to grow to $1.6 billion by 2015. The
Company's lead product, Aorfix(TM), is an endovascular stent graft
which has been specifically designed to solve the problems that
exist in treating complex tortuous anatomy which is often present
in advanced AAA disease. Aorfix(TM) is currently being
commercialised in the EU, and has been submitted to the FDA for
approval in the U.S.
The Company is headquartered in Oxfordshire, with operations in
Ayrshire and Phoenix, USA.
Further background on the Company can be found at
www.lombardmedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCGGUBWQUPWPPW
Lombard Medical Technologies (LSE:LMT)
Historical Stock Chart
From Jul 2024 to Jul 2024
Lombard Medical Technologies (LSE:LMT)
Historical Stock Chart
From Jul 2023 to Jul 2024